Innovus Pharmaceuticals, Inc. operates as an over-the-counter consumer goods and specialty pharmaceutical company in the United States and Canada. It engages in the development, licensing, and commercialization of non-prescription medicines, consumer care products, supplements, and medical devices to enhance men’s and women’s health and vitality. The company provides approximately 35 products with a focus on categories, such as sexual health, pain management, general muscle health, respiratory, sleep, and diabetic care. Its principal products include Vesele, UriVarx, FlutiCare, Apeaz, Diabasens, Prostagorx, and Sensum. The company markets and sells its products through commercial partners to physicians, urologists, gynecologists, therapists, and other healthcare providers; and directly to consumers through online channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California. As of February 14, 2020, Innovus Pharmaceuticals, Inc. operates as a subsidiary of Aytu BioScience, Inc.